Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-14-014912
Filing Date
2014-02-27
Accepted
2014-02-27 17:07:02
Documents
2
Period of Report
2014-02-19

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 3205
2 EX-24 DOCUMENT attachment1.htm EX-24 2472
  Complete submission text file 0001209191-14-014912.txt   6992
Mailing Address 1301 2ND AVE. SUITE 3200 SEATTLE WA 98101
Business Address 1301 2ND AVE. SUITE 3200 SEATTLE WA 98101 206-219-7815
DENDREON CORP (Issuer) CIK: 0001107332 (see all company filings)

EIN.: 223203193 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1301 2ND AVE SEATTLE WA 98101
Business Address
Pacheco Silvio (Reporting) CIK: 0001600281 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35546 | Film No.: 14650047